US Stock MarketDetailed Quotes

INMB INmune Bio

Watchlist
  • 9.630
  • +0.180+1.90%
Close Jun 3 16:00 ET
  • 9.490
  • -0.140-1.45%
Post 18:55 ET
190.50MMarket Cap-5015P/E (TTM)

INmune Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-63.16%14K
-58.56%155K
-71.13%28K
-56.12%43K
187.50%46K
-76.69%38K
106.63%374K
-40.49%97K
600.00%98K
16K
Operating revenue
-63.16%14K
-58.56%155K
-71.13%28K
-56.12%43K
187.50%46K
-76.69%38K
106.63%374K
-40.49%97K
600.00%98K
--16K
Cost of revenue
Gross profit
Operating expense
70.73%11.03M
13.57%29.9M
46.49%8.41M
13.66%8.57M
0.83%6.46M
-2.71%6.46M
-10.26%26.33M
-37.57%5.74M
-16.54%7.54M
-2.29%6.4M
Selling and administrative expenses
0.43%2.34M
3.94%9.62M
3.05%2.4M
8.56%2.59M
4.24%2.31M
-0.17%2.33M
5.31%9.26M
9.60%2.33M
-5.29%2.38M
5.98%2.22M
-General and administrative expense
0.43%2.34M
3.94%9.62M
3.05%2.4M
8.56%2.59M
4.24%2.31M
-0.17%2.33M
5.31%9.26M
9.60%2.33M
-5.29%2.38M
5.98%2.22M
Research and development costs
110.33%8.69M
18.78%20.27M
76.16%6.01M
16.01%5.99M
-0.98%4.15M
-4.08%4.13M
-16.92%17.07M
-51.75%3.41M
-20.87%5.16M
-6.16%4.19M
Operating profit
-71.52%-11.02M
-14.60%-29.74M
-48.51%-8.38M
-14.58%-8.53M
-0.36%-6.41M
0.85%-6.42M
10.98%-25.95M
37.52%-5.64M
17.49%-7.44M
2.53%-6.39M
Net non-operating interest income expense
Other net income (expense)
92.92%-8K
80.19%-267K
84.82%-29K
87.59%-35K
80.00%-90K
73.41%-113K
-13.56%-1.35M
70.20%-191K
35.47%-282K
-345.54%-450K
Other non- operating income (expenses)
92.92%-8K
80.19%-267K
84.82%-29K
87.59%-35K
80.00%-90K
73.41%-113K
-13.56%-1.35M
70.20%-191K
35.47%-282K
-345.54%-450K
Income before tax
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
18.32%-7.73M
-2.75%-6.84M
Income tax
Net income
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
18.32%-7.73M
-2.75%-6.84M
Net income continuous Operations
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
18.32%-7.73M
-2.75%-6.84M
Minority interest income
Net income attributable to the parent company
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
18.32%-7.73M
-2.75%-6.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
18.32%-7.73M
-2.75%-6.84M
Basic earnings per share
-69.44%-0.61
-9.87%-1.67
-46.88%-0.47
-11.63%-0.48
5.26%-0.36
7.69%-0.36
19.15%-1.52
41.82%-0.32
21.82%-0.43
13.64%-0.38
Diluted earnings per share
-69.44%-0.61
-9.87%-1.67
-46.88%-0.47
-11.63%-0.48
5.26%-0.36
7.69%-0.36
19.15%-1.52
41.82%-0.32
21.82%-0.43
13.64%-0.38
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -63.16%14K-58.56%155K-71.13%28K-56.12%43K187.50%46K-76.69%38K106.63%374K-40.49%97K600.00%98K16K
Operating revenue -63.16%14K-58.56%155K-71.13%28K-56.12%43K187.50%46K-76.69%38K106.63%374K-40.49%97K600.00%98K--16K
Cost of revenue
Gross profit
Operating expense 70.73%11.03M13.57%29.9M46.49%8.41M13.66%8.57M0.83%6.46M-2.71%6.46M-10.26%26.33M-37.57%5.74M-16.54%7.54M-2.29%6.4M
Selling and administrative expenses 0.43%2.34M3.94%9.62M3.05%2.4M8.56%2.59M4.24%2.31M-0.17%2.33M5.31%9.26M9.60%2.33M-5.29%2.38M5.98%2.22M
-General and administrative expense 0.43%2.34M3.94%9.62M3.05%2.4M8.56%2.59M4.24%2.31M-0.17%2.33M5.31%9.26M9.60%2.33M-5.29%2.38M5.98%2.22M
Research and development costs 110.33%8.69M18.78%20.27M76.16%6.01M16.01%5.99M-0.98%4.15M-4.08%4.13M-16.92%17.07M-51.75%3.41M-20.87%5.16M-6.16%4.19M
Operating profit -71.52%-11.02M-14.60%-29.74M-48.51%-8.38M-14.58%-8.53M-0.36%-6.41M0.85%-6.42M10.98%-25.95M37.52%-5.64M17.49%-7.44M2.53%-6.39M
Net non-operating interest income expense
Other net income (expense) 92.92%-8K80.19%-267K84.82%-29K87.59%-35K80.00%-90K73.41%-113K-13.56%-1.35M70.20%-191K35.47%-282K-345.54%-450K
Other non- operating income (expenses) 92.92%-8K80.19%-267K84.82%-29K87.59%-35K80.00%-90K73.41%-113K-13.56%-1.35M70.20%-191K35.47%-282K-345.54%-450K
Income before tax -68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M18.32%-7.73M-2.75%-6.84M
Income tax
Net income -68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M18.32%-7.73M-2.75%-6.84M
Net income continuous Operations -68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M18.32%-7.73M-2.75%-6.84M
Minority interest income
Net income attributable to the parent company -68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M18.32%-7.73M-2.75%-6.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M18.32%-7.73M-2.75%-6.84M
Basic earnings per share -69.44%-0.61-9.87%-1.67-46.88%-0.47-11.63%-0.485.26%-0.367.69%-0.3619.15%-1.5241.82%-0.3221.82%-0.4313.64%-0.38
Diluted earnings per share -69.44%-0.61-9.87%-1.67-46.88%-0.47-11.63%-0.485.26%-0.367.69%-0.3619.15%-1.5241.82%-0.3221.82%-0.4313.64%-0.38
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg